세계 단백질 어세이 시장은 2024년부터 2031년까지 9.3%의 CAGR로 2031년까지 43억 6,000만 달러에 달할 것으로 예측됩니다.
이 보고서는 광범위한 2차 및 1차 연구와 단백질 어세이 시장 시나리오에 대한 심층 분석을 통해 주요 산업 촉진요인, 시장 억제요인, 도전 과제 및 기회 분석으로 구성되어 있습니다. 단백질 어세이 시장의 성장은 제약 연구 개발 비용 증가, 신약 개발 및 약물 개발에서 단백질 어세이의 사용 증가, 식품 및 음료 산업의 성장, 임상 진단 검사에서 단백질 어세이의 사용 증가로 인해 발생합니다. 그러나 단백질 어세이 장비의 높은 비용은 시장 성장을 저해하는 요인입니다.
또한, 단백질체학 연구에 대한 관심이 높아지고 맞춤형 의료에 단백질 어세이가 활용되면서 시장 성장의 기회가 될 것으로 예상됩니다. 그러나 숙련된 전문가 부족과 복잡한 시료로 인한 오류 가능성이 높다는 점은 시장 성장에 큰 걸림돌로 작용하고 있습니다.
(참고 : 상위 5개사 SWOT 분석을 제공합니다)
Protein Assays Market by Type (Dye-based, Copper-based) Technology (Fluorescence, Absorbance, Colorimetric) Offering (Reagent, Kit, Instrument) Application (R&D, Drug Discovery, Diagnostics) End User (Pharmaceutical, Hospital)-Global Forecast to 2031
The global protein assays market is projected to reach $4.36 billion by 2031 at a CAGR of 9.3% from 2024 to 2031.
Succeeding extensive secondary and primary research and in-depth analysis of the protein assays market scenario, the report comprises the analysis of key industry drivers, restraints, challenges, and opportunities. The growth of the protein assays market is driven by increasing pharmaceutical R&D expenditure, rising use of protein assays in drug discovery & development, growth in the food & beverage industry, and rising use of protein assays in clinical diagnostics tests. However, the high cost of protein assay equipment restrains market growth.
Furthermore, increasing focus on proteomics research and the use of protein assays in personalized medicine is expected to offer market growth opportunities. However, the shortage of skilled professionals and high chances of error with complex samples are a major challenge for the market's growth.
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presences, and key strategic developments adopted by leading market players in the industry over four years (2020-2024). The key players operating in the global protein assays market are Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Revvity, Inc. (U.S.), Merck KGaA (Germany), Abcam plc (U.K.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), Promega Corporation (U.S.), Cell Signaling Technology, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), and Novus Biologicals (U.S.).
Among all the offerings studied in this report, in 2024, the reagents & kits segment is expected to account for the largest share of the protein assays market. The wide availability of consumables, recurring use of protein assay kits, and increasing adoption of these kits by researchers to estimate protein concentration in unknown samples are contributing to the largest share of the segment.
Among all the types studied in this report, in 2024, the dye-based assay segment is expected to account for the largest share of the protein assays market. Dye-based assays have exceptional speed and simplicity, making them suitable for high throughput screening and allowing researchers to process a large number of samples. Such factors support the large market share of this segment.
Among all the technologies studied in this report, in 2024, the absorbance-based protein assay segment is expected to account for the largest share of the protein assays market. Absorbance assays are applied to a wide variety of samples, making them ideal for research applications. Additionally, the reagents used in the assays do not cross-react with each other, increasing the reliability of the method. This is boosting the adoption of absorbance assays, thereby leading to segment growth.
Among all the applications studied in this report, in 2024, the drug discovery segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the increased use of protein assay in life science research, increased spending on pharmaceutical R&D, the need to develop new therapies owing to increasing disease prevalence, and high investments in drug discovery & development.
Among all the end users studied in this report, in 2024, the pharmaceutical & biotechnology research segment is expected to account for the largest share of the protein assays market. The large market share of this segment is attributed to the growing number of research and clinical laboratories, increased investments in R&D, and rising funding for pharmaceutical research. The funding for research laboratories is increasing due to the rising demand for new drugs and therapies, which is driving the demand for protein assays.
An in-depth analysis of the geographical scenario of the global protein assays market provides detailed qualitative and quantitative insights into the five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa), along with the coverage of major countries in each region.
In 2024, North America is expected to account for the largest share of the protein assays market. This regional market's large share is attributed to several factors, including favorable government initiatives supporting research and development, substantial R&D investments by pharmaceutical and biotechnology companies in drug and biomarker development, increased healthcare expenditures, the growing prevalence of chronic diseases, and the presence of key market players in the region.
Protein Assays Market Assessment-by Offering
Protein Assays Market Assessment-by Type
Note: Other assay types consist of test strip-based and fluorescent protein assays.
Protein Assays Market Assessment-by Technology
Protein Assays Market Assessment-by Application
Note: Other applications include raw material inspection and forensic proteomics
Protein Assays Market Assessment-by End User
Note: Other end users consist of academic institutes & research centers, forensic labs, and agriculture companies
Protein Assays Market Assessment-by Geography
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)